Ensysce Biosciences (ENSCW) Current Taxes (2017 - 2020)
Ensysce Biosciences (ENSCW) reported Current Taxes of $260404.0 for Q4 2020, down 90.6% year-over-year from $2.8 million in Q1 2020, and up 107.2% quarter-over-quarter from $125677.0 in Q3 2020.
Ensysce Biosciences (ENSCW) Current Taxes (2017 - 2020) Analysis & Trends
Ensysce Biosciences (ENSCW) has 4 years of Current Taxes data on file, last reported at $260404.0 in Q4 2020.
- Current Taxes for Q4 2020 came in at $260404.0, down 90.6% year-over-year; the trailing twelve-month figure through Dec 2020 was $260404.0 (down 90.6% YoY), and the FY2020 annual result was $260404.0, down 90.6% from the prior year.
- Current Taxes improved to $260404.0 in Q4 2020 per ENSCW's latest filing, from $125677.0 in the prior quarter.
- Over five years, Current Taxes peaked at $2.8 million in Q4 2019 and troughed at $339.0 in Q3 2018.
- A 4-year average of $440580.4 and a median of $116750.0 in 2018 frame the typical range for Current Taxes.
- On a YoY basis, Current Taxes climbed as much as 5245.05% in 2020 and fell as far as 90.6% in 2020.
- A 4-year view of Current Taxes shows it stood at $3635.0 in 2017, then plunged by 90.67% to $339.0 in 2018, then soared by 817311.5% to $2.8 million in 2019, then sank by 90.6% to $260404.0 in 2020.
- Business Quant data shows ENSCW's Current Taxes at $260404.0 in Q4 2020, $125677.0 in Q3 2020, and $629914.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 260,404.00 |
| Sep 30, 2020 | 125,677.00 |
| Jun 30, 2020 | 629,914.00 |
| Dec 31, 2019 | 2.77 Mn |
| Jun 30, 2019 | 11,785.00 |
| Mar 31, 2019 | 45,695.00 |
| Sep 30, 2018 | 339.00 |
| Mar 31, 2018 | 116,750.00 |
| Dec 31, 2017 | 3,635.00 |